Bristol Myers' injectable form of Opdivo meets main goal in kidney cancer trial

Bristol Myers Squibb said on
Thursday the injectable form of Opdivo, its blockbuster cancer
drug, was found to be non-inferior in a late-stage trial to the
approved intravenous form used in patients...

Related Keywords

Bengaluru ,Karnataka ,India ,Shinjini Ganguli ,Leroy Leo ,Gina Fusaro ,Bristol Myers Squibb ,Reuters ,Myers Squibb ,Halozyme Therapeutic ,Anild Silva ,Markets ,